FDA Updates & Announcements

FDA Updates and Announcements

The FDA has issued pharmacy alerts or updates for the following prescription medications. If you use any of these medications you may receive communication from MHBP to advise you of steps that you need to take relating to these changes. If you are currently being treated with any of the following medications, please discuss your options for treatment with your healthcare provider.

Bertek and UDL Digitek® (digoxin tablets, USP):

Duragesic

Fentanyl patches

Pergolide (marketed as Permax)

Tegaserod maleate (marketed as Zelnorm)

Quinine drug products